ERIS Lifesciences Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Sep '24
Jun '24
Mar '24
Dec '23
Sep '23
Total Qtr Revenue cr
745.72
721.36
566.07
490.49
508.78
Other Income Qtr Cr6.771.6415.154.203.48
Operating Revenues Qtr738.95719.72550.92486.30505.30

*All values are in Cr.

Operating Expenses Qtr
476.66
469.73
402.49
310.79
324.16
Operating Profit Qtr
262.29
249.99
148.43
175.51
181.14
EBIDT Qtr Cr
269.06
251.63
163.58
179.71
184.62
Depreciation Qtr
80.48
75.94
53.90
45.72
42.09
Net Profit Qtr
91.59
83.18
70.96
102.74
123.43
Basic EPS Qtr
6.73
6.11
5.22
7.55
9.08
Open Demat Account
+91 -

personImage
Open Demat Account
+91 -